The Safety and Efficacy of Rapamycin on Communicating Hydrocephalus Secondary to Intraventricular Hemorrhage

NCT06563817 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Communicating Hydrocephalus
Cerebral Intraventricular Hemorrhage
Secondary Normal Pressure Hydrocephalus
Post Hemorrhagic Hydrocephalus

Interventions

DRUG: Rapamycin

Sponsor

Beijing Tiantan Hospital